Jiajie Fang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiajie Fang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Guo-Sheng Yang
Department of Urology, First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China
1 shared publication - Hai Jiang
Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China
1 shared publication Liping Xie
Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
1 shared publicationQiqi Mao
Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
1 shared publication- Shuo Wang
Shanghai Institute of Nutrition and Health
1 shared publication - Wei Wang
Department of Psychology, Norwegian University of Science and Technology, Trondheim, Norway
1 shared publication
Latest Publications
- Open Access
- 24 January 2020
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 35 (1) , 57-64
Lower circulating adiponectin is associated with higher risk of renal cell carcinoma: A meta-analysis
Changes in circulating adiponectin have been related to the risks of various cancers. However, the association between circulating adiponectin and the risk of renal cell carcinoma has not been fully determined. A meta-analysis was performed to evaluate the relationship between circulating adiponectin and renal cell carcinoma risk. Observational studies that evaluated the association between circulating adiponectin and renal cell carcinoma risk were identified via a systematic search of PubMed and Embase databases. The difference between circulating adiponectin in renal cell carcinoma cases and healthy controls, and the multivariable adjusted association between circulating adiponectin and renal cell carcinoma risk were evaluated. A random effects model was used if significant heterogeneity existed; otherwise a fixed effects model was applied. Eight case-control studies with 2624 renal cell carcinoma cases and 2904 healthy controls were included. Pooled results showed that circulating adiponectin was significantly lower in renal cell carcinoma cases than in healthy controls (mean difference = −1.08 ug/mL; 95% confidence interval (CI) −1.62, −0.54; P < 0.001). Higher circulating adiponectin was independently associated with a significantly lowered risk of renal cell carcinoma (adjusted odds ratio for 1 SD increment of adiponectin = 0.78; 95% CI: 0.63, 0.96; P = 0.02). Subgroup analyses according to characteristics including study design, ethnics of participants, blood samples, numbers of participants, mean ages of participants, and study quality showed consistent results. Lower circulating adiponectin is associated with increased risk of renal cell carcinoma. The potential pathophysiological mechanisms underlying the role of circulating adiponectin in the pathogenesis of renal cell carcinoma deserve further investigation.
- 24 January 2020
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 35 (1) , 57-64
Open AccessLower circulating adiponectin is associated with higher risk of renal cell carcinoma: A meta-analysis
Changes in circulating adiponectin have been related to the risks of various cancers. However, the association between circulating adiponectin and the risk of renal cell carcinoma has not been fully determined. A meta-analysis was performed to evaluate the relationship between circulating adiponectin and renal cell carcinoma risk. Observational studies that evaluated the association between circulating adiponectin and renal cell carcinoma risk were identified via a systematic search of PubMed and Embase databases. The difference between circulating adiponectin in renal cell carcinoma cases and healthy controls, and the multivariable adjusted association between circulating adiponectin and renal cell carcinoma risk were evaluated. A random effects model was used if significant heterogeneity existed; otherwise a fixed effects model was applied. Eight case-control studies with 2624 renal cell carcinoma cases and 2904 healthy controls were included. Pooled results showed that circulating adiponectin was significantly lower in renal cell carcinoma cases than in healthy controls (mean difference = −1.08 ug/mL; 95% confidence interval (CI) −1.62, −0.54; P < 0.001). Higher circulating adiponectin was independently associated with a significantly lowered risk of renal cell carcinoma (adjusted odds ratio for 1 SD increment of adiponectin = 0.78; 95% CI: 0.63, 0.96; P = 0.02). Subgroup analyses according to characteristics including study design, ethnics of participants, blood samples, numbers of participants, mean ages of participants, and study quality showed consistent results. Lower circulating adiponectin is associated with increased risk of renal cell carcinoma. The potential pathophysiological mechanisms underlying the role of circulating adiponectin in the pathogenesis of renal cell carcinoma deserve further investigation.
- Open Access
- 21 August 2017
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 14 (4) , 3519-3522
Benefits of urethroplasty for managing urethral amyloidosis: A case report
Urethral amyloidosis is a rare condition in which eosinophilic amyloid proteins are deposited in the urethra. Only a small number of reports on urethral amyloidosis have been published. Increased interest has been associated with this disease due to its clinical similarities with urothelial carcinoma. A biopsy of the lesion and a histological examination are essential for the correct diagnosis. Conservative management has been suggested by various urologists as the optimal treatment approach for urethral amyloidosis; however, recurrence and urethral stricture are common, and typically further treatment is required. Urethroplasty has been used in a limited number of urethral amyloidosis cases, with beneficial short-term outcomes; however, long-term follow-up data are lacking. The present case report describes the cases of 2 patients with urethral amyloidosis who underwent urethroplasty without recurrence or progression for >2 years. These findings indicate that urethroplasty is beneficial for the long-term management of urethral amyloidosis.
- 21 August 2017
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 14 (4) , 3519-3522
Open AccessBenefits of urethroplasty for managing urethral amyloidosis: A case report
Urethral amyloidosis is a rare condition in which eosinophilic amyloid proteins are deposited in the urethra. Only a small number of reports on urethral amyloidosis have been published. Increased interest has been associated with this disease due to its clinical similarities with urothelial carcinoma. A biopsy of the lesion and a histological examination are essential for the correct diagnosis. Conservative management has been suggested by various urologists as the optimal treatment approach for urethral amyloidosis; however, recurrence and urethral stricture are common, and typically further treatment is required. Urethroplasty has been used in a limited number of urethral amyloidosis cases, with beneficial short-term outcomes; however, long-term follow-up data are lacking. The present case report describes the cases of 2 patients with urethral amyloidosis who underwent urethroplasty without recurrence or progression for >2 years. These findings indicate that urethroplasty is beneficial for the long-term management of urethral amyloidosis.
- Open Access
- 1 September 2006
- Published by Medknow in Asian Journal of Andrology
- Vol. 8 (5) , 569-575
Effect of cocaine on germ cell apoptosis in rats at different ages
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.
- 1 September 2006
- Published by Medknow in Asian Journal of Andrology
- Vol. 8 (5) , 569-575
Open AccessEffect of cocaine on germ cell apoptosis in rats at different ages
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.